Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.65ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.65ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.45EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.45ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.45ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-20425.8Germany
B.45EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.45EHuang-EGCAGCAGTACGCACACAATC20552637626357R-22758China
B.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.1.165EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.165EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.165ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.165ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.165EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.165EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.165ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.165ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.41 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.41 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.41 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.41 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.41 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.41 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.41 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.41 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.71EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.71ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.71ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.71EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.71EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used